Nothing Special   »   [go: up one dir, main page]

Manni et al., 2016 - Google Patents

PhosphoINOSitide-3 Kinase Inhibition In Th17-Dominant Allergic Airway Disease In Mice

Manni et al., 2016

Document ID
2809543584158588828
Author
Manni M
Clay M
McHugh K
Salmon M
Kolls J
Alcorn J
Publication year
Publication venue
C31. EXPERIMENTAL ASTHMA THERAPIES

External Links

Snippet

hypersecretion, and airway hyperresponsiveness (AHR). Th17 cells, which mediate neutrophil recruitment, are thought to play a role in asthma pathogenesis, especially those asthmatics with disease that fails to respond to standard glucocorticoid therapy …
Continue reading at www.atsjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Similar Documents

Publication Publication Date Title
NZ718144A (en) Methods and compositions comprising purified recombinant polypeptides
Halim et al. New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung
Rosenberg et al. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention
Manni et al. PhosphoINOSitide-3 Kinase Inhibition In Th17-Dominant Allergic Airway Disease In Mice
WO2017126700A9 (en) Inhibitor of activity of vesicular nucleotide transporter
Mcnamara et al. Lung-Selective Pan-JAK-Inhibition with TD-8236 Has Broad Anti-Inflammatory Effects on Eosinophilic and Neutrophilic Airway Inflammation in WT and IL-4Rα Deficient Mice
Llanos-Ackert et al. Asthma control in patients with severe eosinophilic asthma treated with mepolizumab
Beckert et al. IL5 And IL13-Antibodies Specifically Inhibit Asthma Features In A Cytokine Induced Mouse Model
Gozdz et al. Club Cell Protein-16 Modifies Airway Inflammation in an IL-13 Model of Induced Airway Responses
Shi et al. Role of miR-466i in Mesenchymal Stem Cell Microvesicles Treating Pneumonia Caused by Drug-Resistant Pseudomonas Aeruginosa
Caillaud et al. C35 ASTHMA THERAPY I: Pfrench Survey Of Omalizumab Prescription By Pulmonologists For Elderly Patients With Severe Asthma
Lawrie et al. Enhanced Therapeutic Efficacy of Vasodilator Therapy in Combination with a Novel Human Anti-OPG Antibody in Experimental Pulmonary Arterial Hypertension
Pemberton et al. Amelioration of Rhinovirus Induced Airway Inflammation by Serpin B1
Ashino et al. Janus kinase (JAK) 3 inhibitor, R256, attenuates allergen-induced airway hyperresponsiveness and airway inflammation in mice
Komiya et al. C26 ASTHMA IN INFANTS AND CHILDREN: Neutrophil Elastase Restores Muscarinic 3 Receptor (m3r) Expression That Has Been Suppressed By Interleukin (il)-13
Tuinman et al. High-Dose Acetylsalicylic Acid Is Superior To Low Dose And/Or Clopidogrel In Attenuating LPS-Induced Lung Injury In Mice
Banzato et al. The Role of Alpha 7 Nicotinic Receptor on Lung Alterations in an Experimental Model of Emphysema Induced by Elastase
Wooten et al. Pneumococcal Phosphodiesterase 2 Mutation Elicits a Unique Type I Interferon Expression in Macrophages
Moarbes et al. Inhibitory Activity of STAT6-IP on IL-33-Mediated-IL-13 Production and Macrophage Polarization in an Innate Murine Allergy Model
Chen et al. The Impact of Different Inhaled Corticosteroids, Bronchodilators and Azithromycin on Lung Microbiota in the Murine Model of Emphysema
Amison P2Y1 Antagonism But Not P2Y12 Antagonism Suppresses Pulmonary Leukocyte Recruitment In Vivo
Melim et al. In vivo characterization of ABT-308, a potent anti-IL-13 antibody for the treatment of asthma
Kilpatrick et al. The Unfolded Protein Response (UPR) Regulates Cytokine Expression In Human Monocyte-Derived Macrophages (MDMS) And Alveolar Macrophages (AMS): Exaggerated Responses In The M1 Phenotype
Brandenberger et al. Lipopolysaccharide-induced lung injury is more severe in old compared to young mice
Narayanan et al. D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Anti-Inflammatory Effects Of Combined Indacaterol And Glycopyrronium On Lung Structural Cells